1-(6'-NITRO-1'-PIPEROYL)-1,2,3,4-TETRAHYDRO-BETA-CARBOLINE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | Cl7HLLhk3WD |
|---|---|
| InChI | InChI=1S/C18H15N3O4/c22-21(23)17-12(5-6-14-18(17)25-9-24-14)15-16-11(7-8-19-15)10-3-1-2-4-13(10)20-16/h1-6,15,19-20H,7-9H2 |
| InChIKey | UZUVPSXDEVELNB-UHFFFAOYSA-N |
| Mol Weight | 337.34 g/mol |
| Molecular Formula | C18H15N3O4 |
| Exact Mass | 337.106256 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
METHYL-TRANS-1'-(4-METHOXYPHENYL)-2',3',4',9'-TETRAHYDROSPIRO-[CYCLOPROPANE-1,4'-1H-BETA-CARBOLINE]-3'-CARBOXYLATE
Methyl (cis)-1'-(p-methoxyphenyl)-2',3',4',9'-tetrahydro-spiro[cyclopropane-1,4'-(1H)-.beta.-carboline]-3'-carboxylate
1H-Pyrido[3,4-b]indole-3-carboxylic acid, 2,3,4,9-tetrahydro-2-hydroxy-1-(3,4,5-trimethoxyphenyl)-, ethyl ester, cis-
Dimethyl 2-methoxy-5-methylpyrido[3,2-b]indole-8,9-dicarboxylate
1H-Indolizino[8,7-b]indole-1-propanoic acid, .alpha.-cyano-1-ethyl-2,3,5,6,11,11b-hexahydro-3-oxo-, methyl ester
1-butyl-5-(6-chloro-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-2-ium-1-yl)-6-oxo-2-thioxo-1,2,3,6-tetrahydropyrimidin-4-olate
HHJOUVUPVDLVJS-UHFFFAOYSA-N
(-)-(1R,4S)-12-Allyl-2-(2,4-dimethoxybenzyl)-6-methyl-2,3,4,5-tetrahydro-4,1-iminomethano-1H-azepino[3,4-b]quinoline
Carbazomycin H
7-methoxy-2-(4-methoxyphenyl)-1'-(methylsulfonyl)-1,10b-dihydrospiro[benzo[e]pyrazolo[1,5-c][1,3]oxazine-5,4'-piperidine]
| Title | Journal or Book | Year |
|---|---|---|
| The Preparation and Evaluation of 1-Substituted 1,2,3,4-Tetrahydro- and 3,4-Dihydro-.BETA.-carboline Derivatives as Potential Antitumor Agents | Chemical and Pharmaceutical Bulletin | 2005 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.